Log in
Enquire now

List of PureTech patents

List of PureTech patents
List of Ocata Therapeutics patents
List of Flow Labs patents
List of ARM Ltd. patents
List of companies in Rarestone Capital's investment portfolio
Companies in the Social industry
Patents where
Current Assignee
Name
is
PureTechPureTech
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10369143 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation

Patent 10369143 was granted and assigned to PureTech on August, 2019 by the United States Patent and Trademark Office.

PureTech
PureTech
PureTech
PureTech
United States Patent and Trademark Office
United States Patent and Trademark Office
10369143
August 6, 2019
‌
US Patent 10369144 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation

Patent 10369144 was granted and assigned to PureTech on August, 2019 by the United States Patent and Trademark Office.

PureTech
PureTech
PureTech
PureTech
United States Patent and Trademark Office
United States Patent and Trademark Office
10369144
August 6, 2019
‌
US Patent 10265311 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation

Patent 10265311 was granted and assigned to PureTech on April, 2019 by the United States Patent and Trademark Office.

PureTech
PureTech
PureTech
PureTech
United States Patent and Trademark Office
United States Patent and Trademark Office
10265311
April 23, 2019
‌
US Patent 10238643 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation

Patent 10238643 was granted and assigned to PureTech on March, 2019 by the United States Patent and Trademark Office.

PureTech
PureTech
PureTech
PureTech
United States Patent and Trademark Office
United States Patent and Trademark Office
10238643
March 26, 2019
‌
US Patent 10695339 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation

Patent 10695339 was granted and assigned to PureTech on June, 2020 by the United States Patent and Trademark Office.

PureTech
PureTech
PureTech
PureTech
United States Patent and Trademark Office
United States Patent and Trademark Office
10695339
June 30, 2020
5 results
0 selected
5 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us